Chemical Chaperone Could Open Door To Treatment Of Neurological Disorder
Chemical Chaperone Could Open Door To Treatment Of Neurological Disorder
An unexpected finding turned out to be a clue leading researchers to propose a new treatment approach for Niemann-Pick disease, a rare, deadly neurodegenerative disorder. They believe the approach also could be useful for more common diseases -- such as cystic fibrosis -- that stem from a similar type of defect.
Nurses As 'Soft Targets' Of Drug Company Promotion
Nursing education fails to prepare graduates to deal with the pharmaceutical industry's promotional tactics, and many nurses appear to accept promotional materials uncritically, according to an analysis of the nursing literature recently published.
Iodized Table Salt May Be Low In Iodine, Raising Health Concerns
Amid concern that people in the United States are consuming inadequate amounts of iodine, scientists in Texas have found that 53 percent of iodized salt samples contained less than the U.S. Food and Drug Administration (FDA) recommended level of this key nutrient. Iodized table salt is the main source of iodine for most individuals, they note in a new study.
High Blood Pressure Pill Cuts Risk Of Parkinson's Disease
People taking a widely used group of drugs known as calcium channel blockers to treat high blood pressure also appear to be cutting their risk of Parkinson's disease, according to a new study. The study found people who were currently long-term users of calcium channel blockers to treat high blood pressure lowered their risk of Parkinson's disease by 23 percent compared to people who didn't take the drugs. There was no such effect among people taking ACE inhibitors, AT II antagonists and beta blockers.
Freshwater Fish Invasions The Result Of Human Activity
Mapping worldwide freshwater fish invasions allowed the identification of major invasion hot spots and demonstrated that economic activity is the main determinant of freshwater fish invasions at the global scale.
posted by wealthfreely at
11:18 AM
0 Comments:
Post a Comment
<< Home